Search by Drug Name or NDC
NDC 10135-0763-03 Loratadine Allergy Relief 10 mg/1 Details
Loratadine Allergy Relief 10 mg/1
Loratadine Allergy Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is LORATADINE.
Product Information
| NDC | 10135-0763 |
|---|---|
| Product ID | 10135-763_09bac992-802d-5dee-e063-6394a90a7e0d |
| Associated GPIs | |
| GCN Sequence Number | 018698 |
| GCN Sequence Number Description | loratadine TABLET 10 MG ORAL |
| HIC3 | Z2Q |
| HIC3 Description | ANTIHISTAMINES - 2ND GENERATION |
| GCN | 60563 |
| HICL Sequence Number | 007605 |
| HICL Sequence Number Description | LORATADINE |
| Brand/Generic | Generic |
| Proprietary Name | Loratadine Allergy Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Loratadine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | LORATADINE |
| Labeler Name | Marlex Pharmaceuticals, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076134 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10135-0763-03 (10135076303)
| NDC Package Code | 10135-763-03 |
|---|---|
| Billing NDC | 10135076303 |
| Package | 300 TABLET in 1 BOTTLE (10135-763-03) |
| Marketing Start Date | 2022-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |